Global Neurodegenerative Disease Market Size, Share, and COVID-19 Impact Analysis, By Disease (Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, and Multiple Sclerosis), By Route of Administration (Oral, Injectable, Transdermal, and Others), By Drug (Cholinesterase Inhibitors, Gene Therapy, NMDA Receptor Antagonists, and Dopaminergic Drugs), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.
$5550
Total
$5550
Need assistance?
Call us or write to us:
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies